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2Abstract
Background: Asthma is not the key focus of prevention strategies. A healthy lifestyle
index (HLI) was developed to examine the combined effect of modifiable lifestyle
factors on asthma, rhinoconjunctivitis, and eczema using data from the International
Study of Asthma and Allergies in Childhood (ISAAC) Phase Three.
Methods: Information on symptoms of asthma, rhinoconjunctivitis, eczema and several
lifestyle factors was obtained from children aged 6–7 years through written
questionnaires. The HLI combined five lifestyle factors: no parental smoking, child’s
adherence to Mediterranean diet, child’s healthy body mass index, high physical activity
and non-sedentary behaviour. The association between the HLI and risk of asthma,
rhinoconjunctivitis, and eczema was evaluated using multilevel mixed-effects logistic
regression models.
Findings: Data of 70795 children from 37 centres in 19 countries were analysed. Each
additional healthy lifestyle factor was associated with a reduced risk of current wheeze
(OR=0.87, 95% CI 0.84-0.89), asthma ever (OR=0.89, 95% CI 0.87-0.92), current
symptoms of rhinoconjunctivitis (OR=0.95, 95% CI 0.92-0.97), and current symptoms
of eczema (OR=0.92, 95% CI 0.92-0.98). If associations were causal, a combination of
four or five healthy lifestyle factors would result into a reduction up to 16% of asthma
cases (ranging from 2.7 to 26.3% according to region of the world).
Conclusions: Although causality cannot be established from this study, results suggest
that interventions to improve multiple modifiable lifestyle factors should be considered
and their efficacy assessed to reduce the burden asthma and allergy in childhood.
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3Key messages
 What is the key question?
What is the combined effect of common modifiable lifestyle factors on asthma,
rhinoconjunctivitis, and eczema in childhood?
 What is the bottom line?
This large worldwide multicentre cross-sectional study found that with each point
added to a child’s healthy lifestyle index (i.e. no parental smoking, child’s healthy
body mass index, adherence to a Mediterranean diet, physical activity, and non-
sedentary behaviour) the risk of current wheeze and reported asthma ever fell by
13% and 11%, respectively. If associations were causal, adherence to a combination
of four or five healthy lifestyle factors would theoretically prevent up to 16% of
asthma cases.
 Why read on?
Although causality cannot be established from this study, researchers should consider
adapting and assessing the efficacy of public health interventions modifying multiple
lifestyle factors to reduce the burden of asthma.
4Introduction
Asthma is currently the most common chronic disease in childhood worldwide.1 Higher
prevalence rates of asthma have been reported in Western countries and in those that are
English speaking; however, in the last two decades the prevalence of asthma there has
changed little globally and even declined in some Western countries.2 Most people
affected are in low- and middle-income countries,3 where asthma prevalence is
estimated to be increasing fastest presumably because of their progressive
“westernisation” of environmental and lifestyle factors.4
The aetiology of asthma remains largely unknown but it is likely a multifactorial and
heterogeneous condition, involving combined or interacting effects of non-modifiable
(i.e. heredity and sex) and modifiable (i.e. environment and behaviour) risk factors.5
The International Study of Asthma and Allergies in Childhood (ISAAC) has revealed
several modifiable parental and child lifestyle factors to be individually associated with
the risk of asthma and allergy symptoms in childhood. These include second-hand
tobacco smoke exposure from parental smoking,6 some specific dietary patterns (e.g.
Mediterranean diet and fast food),7-9 child’s overweight and obesity,10,11 and child’s
physical activity and sedentary behaviour;11 which are also the focus of population-wide
approaches to prevention of cardiovascular disease and cancer in adults.
Although it would be pertinent to quantify the joint effect of modifiable lifestyle factors
on the risk of childhood asthma and allergic conditions, only one previous small study
conducted among 609 Puerto Rican children aged 6–14 years has assessed the potential
synergistic effects of several risk factors (obesity, early-life second hand smoking,
unhealthy diet, and gun violence exposure) on asthma risk.12
In this large study, we developed a healthy lifestyle index (HLI) composed of five
potentially modifiable lifestyle factors – parental smoking, child’s adherence to
Mediterranean diet, healthy body mass index (BMI), child’s physical activity and
sedentary behaviour – and examined the association of this index with risk of asthma,
rhinoconjunctivitis, and eczema symptoms using data from ISAAC Phase Three. We
used this multidimensional lifestyle approach to estimate the impact of potential
prevention strategies (mainly recommended for non-respiratory diseases) upon the
population burden of asthma, rhinitis, and eczema in childhood.
5Methods
Study participants
ISAAC Phase Three (2000-2003) was a multi-centre, multi-country, cross-sectional
study of children (aged 6-7 years) and adolescents (aged 13-14 years) chosen from a
random sample of schools in each defined geographical area.13 The present study is
based on data for healthy lifestyle behaviour in 70795 children aged 6-7 years from 37
centres in 19 countries.
Child’s health outcomes assessment
Information on symptoms of asthma, rhinoconjunctivitis, and eczema was obtained
from parents/guardians of the child through the ISAAC Phase Three core questionnaire
(http://isaac.auckland.ac.nz). Current symptoms of asthma were indicated by current
wheeze defined as a positive answer to the written question ‘Has your child had
wheezing or whistling in the chest in the past 12 months?’. Reported asthma ever was
defined as a positive response to the question: ‘Has your child ever had asthma?’
Current symptoms of rhinoconjunctivitis were determined by positive answers to two
questions: ‘In the past 12 months, has your child had a problem with sneezing, or a
runny, or blocked nose when he/she did not have a cold or the flu?’ If yes: ‘In the past
12 months, has this nose problem been accompanied by itchy-watery eyes?’. Hay fever
ever was defined as an affirmative answer to the question ‘Has your child ever had hay
fever?’.
Current symptoms of eczema were determined by positive answers to: ‘Has your child
ever had an itchy rash which was coming and going for at least six months?’ If yes:
‘Has your child had this itchy rash at any time in the past 12 months?’ If yes: ‘Has this
itchy rash at any time affected any of the following places: the folds of the elbows,
behind the knees, in front of the ankles, under the buttocks, or around the neck, ears or
eyes?’. Reported eczema ever was determined by a positive answer to: ‘Has your child
ever had eczema?’.
Assessment of lifestyle factors and derivation of the healthy lifestyle index (HLI)
Information on lifestyle factors was collected from parents/guardians of the child using
the ISAAC Phase Three environmental questionnaire (http://isaac.auckland.ac.nz). The
following questions were used to assess smoking habits by the parents of children: 1)
Does your child’s mother (or female guardian) smoke cigarettes?; and 2) Does your
child’s father (or male guardian) smoke cigarettes?. Parents were also asked about the
weight and height of their children, which was used to calculate the body mass index
(BMI) in kg/m2. Overweight and obesity were defined according to the cut-off points of
child’s BMI defined by Cole et al. for each age group and sex,14 which provides cut-off
points for overweight (25 kg/m2) and obesity (30 kg/m2) from the age of 2 years and the
projection of these values at the age of 18 years.
The environmental questionnaire also included questions about the frequency of
consumption over the past year (never or occasionally, one or twice per week, three or
more times a week) of the following foods: meat, seafood (including fish), fruit,
6vegetables, pulses, cereal, pasta, rice, butter, margarine, nuts, potatoes, milk, eggs and
fast food/burgers. A score of the ‘Mediterranean diet’ pattern was developed according
to the consumption frequency of these food items based on the score used by
Psaltopoulou et al.15 Fruit, seafood, vegetables, pulses, cereal, pasta, rice, and potatoes
were considered ‘‘pro-Mediterranean’’ foods and eating each of these foods was rated 0
(never or occasionally), 1 (one or twice per week) or 2 (three or more times a week)
points. Meat, milk, and fast food/burgers were considered ‘‘anti-Mediterranean’’ foods
and eating each of these was rated 0 (three or more times a week), 1 (one or twice per
week) or 2 (never or occasionally) points. In contrast to the score by Psaltopoulou et
al.,15 the ISAAC questionnaire did not allow adjustment of food consumption to energy
intake. The points for each of the eleven items were added up to a summary score.
The amount of exercise done by the child was assessed by the question: ‘How many
times a week does your child engage in vigorous physical activity long enough to make
him/ her breathe hard (never or occasionally, once or twice per week, three or more
times per week)?’. Television viewing was assessed by the question: ‘During a normal
week, how many hours a day (24 h) does your child watch television?’ Possible
responses were less than an hour, 1 h but less than 3 h, 3 h but less than 5 h, or 5 h or
more.
We then used a binary score for each evaluated factor to allow easy translation of
findings into a potential policy context. Children were assigned one point for each of the
following factors: mother and father both non-smokers, child has a healthy BMI, child
undertakes vigorous physical activity (at least one time per week), child does not have a
sedentary behaviour (less than one hour a week of television viewing) and adheres to a
Mediterranean diet (Mediterranean diet score above the median value). Finally, the HLI
was constructed by summing the binary score for each of the five modifiable lifestyle
factors which ranged from 0 (least healthy) to 5 (most healthy) points.
Statistical analysis
Each centre included in the analysis had to assess at least 1000 children and have a
response rate higher than 60%. We used multilevel mixed-effects logistic regression to
evaluate the effect of a HLI on the presence of asthma, rhinoconjunctivitis, and eczema
at age 6-7 years, and calculated odds ratios (OR) and 95% confidence intervals (CI).
The HLI was modelled as a continuous and categorical variable with four categories (0
or 1 factor, 2 factors, 3 factors, and 4 or 5 factors), using 0 or 1 factor as the reference
category. In the main model, adjustment was performed for sex of the child, region of
the world (Western Europe, Northern and Eastern Europe, Eastern Mediterranean,
Latin-America, Asia-Pacific and Oceania), and per capita gross national income (GNI)
(categorised by the World Bank as low, lower-middle, upper-middle, and high).16
Centre was included in all models as a random intercept.
Multiple regression analyses investigated whether the associations between HLI and
assessed health outcomes were confounded by other variables in the environmental
questionnaire. Covariates in the multiple regression analyses were maternal education
level (primary, secondary, or tertiary), ever breastfeeding (yes or no), siblings (yes or
no), pets at home (yes or no), and paracetamol use for fever in the first year of life (yes
or no). Covariates that were significantly associated with symptoms at p < 0.05 or
changed the effect estimate ([OR]) ≥10% were included in the final models. In multiple 
7regression analyses, children who had a missing value for any of the covariates were
removed. No imputation was done for missing data, as previous analyses had shown
that little or no bias was introduced by limiting the multiple regression analyses to
children with complete data.17
Stratified analyses were performed for child’s sex, region of the world and GNI. In
addition, a meta-analysis was performed to take into account the heterogeneity between
the centres. Random effects models were used and heterogeneity among centres was
tested by using the Cochran Q test with a significance level of 0.10 and quantified by
using the I2 statistic.
To estimate the proportion or percentage of cases in the entire study population that
could be prevented had all children been following four or all five healthy lifestyle
factors (i.e. lowest-risk exposure group), we derived centre-specific population-
attributable risk fractions (PARFs) (unadjusted for potential confounders) by comparing
the total prevalence for each health outcome in that centre with the prevalence in the
lowest-risk exposure group [PARF = 100% x (total prevalence - lowest-risk group
prevalence) / (total prevalence)]. Analyses were performed using the statistical package
Stata 15.0 (StataCorp, College Station, TX, USA).
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The characteristics of the study participants are shown in Table 1. Median age of
participants was 6.6 ± 0.5 years, and 35122 (49.6%) of them were male. A complete list
of countries, number of centres and children per country, and prevalence of current
wheeze, reported asthma ever, rhinoconjunctivitis, and eczema is shown in
Supplementary Table S1. The healthy lifestyle components were distributed as follows:
57% of children had no exposure to maternal and paternal smoking during childhood,
74.1% of children had a healthy BMI, 41.1% of children adhered to a Mediterranean
diet, 61.9% of children were physically active, and 16.5% of children did not have a
sedentary behaviour pattern (Supplementary Table S2).
Children having a higher HLI score were more likely to be from Western Europe and
Latin America, from countries with high GNI, and were more likely to have mothers
with higher educational level (Table 2). Moreover, children having a higher HLI score
were more likely to be male, ever breastfed, had more siblings and pets at home, and a
lower use of paracetamol for fever in the first year of life (Table 2).
Compared to children with no or one healthy lifestyle factor, the multiple regression
adjusted OR for current wheeze was 0.93 (95% CI 0.87-1.01) for two factors, 0.77 (95%
CI 0.71-0.83) for three factors, and 0.66 (95% CI 0.60-0.72) for four or five factors; P-
trend <0.001 (Table 3). The decreased risk of reported asthma ever was similar to that
for current symptoms of asthma. Estimates were similar in all children and in those with
complete covariate data (Table 3).
Compared to children with no or one healthy lifestyle factor, the multiple regression
adjusted OR for current symptoms of rhinoconjunctivitis was 0.99 (95% CI 0.91-1.07)
for two factors, 0.92 (95% CI 0.84-1.00) for three factors, and 0.86 (95% CI 0.78-0.95)
for four or five factors. No significant risk reduction was observed for hay fever ever. .
In addition, compared with children with no or one healthy lifestyle factor, a reduced
risk of current symptoms of eczema was found among children with two factors
(adjusted OR=0.89, 95% CI 0.81-0.98), three factors (adjusted OR=0.84, 95% CI 0.75-
0.94), and four or five factors (adjusted OR=0.84, 95% CI 0.75-0.94). No association
was found for eczema ever.
The odds ratio estimates were essentially the same after stratification by child’s sex
(Supplementary Table S3). When stratified by region of the world the decreased risk of
current wheeze, current symptoms of rhinoconjunctivitis, and eczema associated with a
higher HLI was primarily observed among children of Western Europe and Latin
America (Supplementary Table S4). Stratified analyses by GNI showed that the reduced
risk of current wheeze, current symptoms of rhinoconjunctivitis, and eczema in relation
to higher HLI was observed among regions with upper-middle and high incomes
(Supplementary Table S5).
When conducting meta-analyses in order to evaluate centre-specific effects, the results
obtained were nearly identical to those obtained in the pooled analyses (Figures 1 and
2). A one-point increase in the HLI score was associated with a decreased risk of current
wheeze (adjusted OR= 0.87, 95% CI 0.84-0.91), reported asthma ever (adjusted
OR=0.89, 95% CI 0.86-0.92), current symptoms of rhinoconjunctivitis (adjusted
9OR=0.96, 95% CI 0.92-1.01), and current symptoms of eczema (adjusted OR=0.95,
95% CI 0.91-0.99). However, significant heterogeneity was detected between centres.
Table 4 shows the PARFs estimated for the lowest-risk HLI group for each assessed
health outcome. Overall the percentages of preventable cases of current symptoms of
asthma, reported asthma ever, current symptoms of rhinoconjunctivitsis, and current
symptoms of eczema attributable to adherence to a combination of 4-5 of these healthy
lifestyle factors were 20%, 16%, 6% and 5%, respectively. Overall, stronger PAFRs
were found among Western Europe and Latin American children.
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Discussion
This large worldwide multicentre cross-sectional study found that in 6-7 years old
children an index based on five potentially modifiable lifestyle factors (i.e. no parental
smoking, child’s healthy body mass index, adherence to a Mediterranean diet, physical
activity, and non-sedentary behaviour) was inversely associated with risk of asthma,
rhinoconjunctivitis, and eczema symptoms. The associations were stronger among
children from Western Europe and Latin America, and from regions with upper-middle,
and higher GNIs. If these associations were causal, 20% of current wheeze and 16% of
reported asthma ever cases would have been prevented had all children adhered to four
or all five healthy lifestyle factors.
In the development and promotion of policies for disease prevention, the importance of
the joint impact of modifiable lifestyle factors on lifespan,18, mortality,19, and chronic
diseases such as cancer,20,21 cardiovascular disease,22 and diabetes has been extensively
investigated and recognized. In contrast, the combined effects of recommended lifestyle
changes on respiratory and allergic diseases in childhood has been rarely studied and
infrequently recognized. This is the only large study, to our knowledge, examining the
combined effect of five modifiable lifestyle risk factors on asthma and allergic diseases
in childhood, providing novel evidence relevant to public health strategies which have
been developed mainly to prevent non-respiratory disease in adults.
Our findings add strong evidence to the only previously published study that
investigated the association between childhood asthma and a combination of several
adverse lifestyle factors.12 This small case-control study conducted among 609 Puerto
Rican children aged 6-14 years showed that the presence of three risk factors compared
with none was associated with ten-to eleven-fold increased odds of asthma.
Furthermore, our results for children are in agreement with a study of adults aged 18-44
years that assessed the combined effects of BMI, smoking, drinking, and solid fuel use
on wheezing symptoms and asthma, and showed that in combination these were
associated with double or triple the risk of asthma.23
When interpreting PARFs, it should be taken into account that these measures rely on
the distribution of lifestyle factors among participants in the present study population. In
this sense, lack of information from some countries may influence representativeness of
some regions of the world. Furthermore, PARs assume that the exposures are causal and
unbiased, but studies with observational design are not sufficiently able to prove this
assumption. Nevertheless, this knowledge may still be useful for tailoring interventions
for lifestyle modification at target population subgroups.
The strengths of this multicentre study include its power, size and multinational nature.
The study participants comprised 37 centres from 19 countries with diverse lifestyle
patterns and a wide range of disease prevalence. Results obtained from meta-analyses of
associations analysed within each study centre were essentially the same than those
obtained from the pooled analyses, with little attenuated adjustment for possible
confounding variables, and clear dose–response relationship, which supports the
consistency of present results.
Limitations of this study should also be considered. First, in order to construct the HLI,
we dichotomized each lifestyle factor according to pre-defined cut-off points. Different
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threshold values would have resulted in different risk estimates. The choice of cut-off
points was mostly based on public health recommendations and was generalized rather
than risk specific. The likely influence of the dichotomization of the variables in
the index is underestimating the true effect of the observed associations. Measurement
error in self-reported variables cannot be ruled out; however, such error would likely
lead to a non-differential bias potentially leading to underestimating the true effects. We
used a simplified diet quality index that may not sufficiently account for the complexity
of diets. Second, reverse causation cannot be ruled out because of the cross-sectional
design of the study (e.g. asthma could reduce vigorous physical exercise and increase
sedentary behaviour; or allergic symptoms could modify some dietary patterns). Third,
we relied on parental report for both the outcomes and the lifestyle factors; however,
recognition of symptoms of asthma, rhinoconjunctivitis, and eczema in children was
based on validated symptom-based written questionnaires.13,24 Fourth, information on
lifestyle factors was obtained retrospectively, which may be subject to underreporting,
recall, and reporting bias, which could have either attenuated or accentuated the
observed associations. Finally, selection bias is also a potential limitation. It is probable
that parents who did not respond to the ISAAC questionnaire differed in terms of their
family lifestyle from those who did respond, but we consider it less likely that the
strength of the association between the HLI and asthma or allergic disease among
children would be seriously affected by this type of selection bias.
In summary, these findings emphasise the potential importance of the combined impact
of modifiable lifestyle factors as preventable influences on childhood asthma and
related allergic conditions. Although causality cannot be established from a study with
this design, our findings suggest that public health interventions which are commonly
justified for prevention of cardiovascular disease and cancer are unlikely to jeopardise
asthma prevention and may be required if the burden of common allergic diseases in
childhood is to be reduced. Further strategies for asthma prevention in childhood
scrutinized in randomised controlled trials should evaluate the impact of interventions
on multiple modifiable lifestyle factors to provide sufficient evidence to lead to
widespread implementation for public health primary prevention.
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(Institut für Epidemiologie und Sozialmedizin, Universität Münster, Germany); C K W
Lai* (Department of Medicine and Therapeutics, The Chinese University of Hong
Kong, SAR China); J Mallol* (Department of Respiratory Medicine, University of
Santiago de Chile, Chile); C F Robertson (Department of Respiratory Medicine, Royal
Children’s Hospital, Parkville, Australia); E A Mitchell (Department of Paediatrics,
Faculty of Medical and Health Sciences, University of Auckland, New Zealand); S
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Haunerschen Kinderklinik de Universität München, Germany); S K Weiland†
(Department of Epidemiology, University of Ulm, Germany); G Weinmayr (Institute of
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Table 1. Healthy Lifestyle Index, child and family characteristics, ISAAC Phase Three
(n=70795).
Healthy Lifestyle Index components
No parental smoking 40357 (57.0)
Child’s healthy weight 52481 (74.1)
Child’s adherence to Mediterranean diet 29084 (41.1)
Child’s physical activity 43836 (61.9)
Child’s no sedentary behavior 11691 (16.5)
Child’s health outcomes
Current wheeze, yes 7343 (10.5)
Missing data 808
Asthma ever, yes 6990 (10.1)
Missing data 1426
Current symptoms of rhino-conjunctivitis 6438 (10.9)
Missing data 11704
Hay fever ever, yes 7031 (10.5)
Missing data 3965
Current symptoms of eczema 5612 (8.5)
Missing data 4 648
Eczema ever, yes 12352 (18.6)
Missing data 4288
Region of the world
Western Europe 21002 (29.6)
Northern and Eastern Europe 8478 (12.0)
Eastern Mediterranean 9474 (13.4)
Latin-America 19825 (28.0)
Asia-Pacific 8615 (12.2)
Oceania 3401 (4.8)
Gross national income
Low income 1438 (2.0)
Low-middle income 11742 (16.6)
Upper-middle income 28383 (40.1)
High income 29232 (41.3)
Maternal education level
Primary 13246 (20.6)
Secondary 28390 (44.1)
Terciary 22716 (35.3)
Missing data 6443
Sex of the child
Male 35122 (49.6)
Female 35673 (50.4)
Child’s age (years) 6.6 (0.5)
Ever breastfed 53496 (79.7)
Missing data 3645
Siblings, yes 54369 (83.6)
Missing data 5803
Pets at home, yes 23765 (35.9)
Missing data 4663
Paracetamol use for fever, yes 44464 (64.9)
Missing data 2315
Data are n (%) or mean (SD).
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Table 2. Characteristics of study participants by Healthy Lifestyle Index score, ISAAC Phase Three.
Healthy lifestyle index points
All 0 or 1 2 3 4 or 5 p value
Participants 70795 11789 (16.6) 23565 (33.3) 23504 (33.2) 11937 (16.9)
Current wheeze 69987 1363 (11.7) 2643 (11.4) 2306 (9.9) 1031 (8.7) <0.001
Asthma ever 69369 1199 (10.4) 2336 (10.1) 2319 (10.0) 1136 (9.7) 0.303
Current symptoms of
rhinoconjunctivitis 59091 1072 (11.1) 2183 (11.2) 2150 (10.8) 1033 (10.3) 0.102
Hay fever ever 66830 1131 (10.2) 2377 (10.7) 2353 (10.6) 1170 (10.4) 0.542
Current symptoms of eczema 66147 976 (8.9) 1846 (8.4) 1863 (8.4) 927 (8.2) 0.200
Eczema ever 66507 1942 (17.7) 4035 (18.3) 4008 (18.1) 2367 (20.9) <0.001
Region of the world 70795
Western Europe 2916 (24.7) 6594 (28.0) 7104 (30.2) 4388 (36.8) <0.001
Northern and Eastern Europe 1939 (16.5) 2958 (12.6) 2437 (10.4) 1144 (9.6)
Eastern Mediterranean 1624 (13.8) 3409 (14.5) 3112 (13.2) 1329 (11.1)
Latin-America 3320 (28.2) 6632 (28.1) 6895 (29.3) 2978 (24.9)
Asia-Pacific 1668 (14.1) 3062 (13.0) 2609 (11.1) 1276 (10.7)
Oceania 322 (2.7) 910 (3.9) 1347 (5.7) 822 (6.9)
Gross national income
per capita
70795
Low income 57 (0.50) 353 (1.50) 630 (2.7) 398 (3.3) <0.001
Low-middle income 2456 (20.8) 4580 (19.4) 3582 (15.2) 1124 (9.4)
Upper-middle income 5144 (43.6) 9534 (40.5) 9318 (39.6) 4387 (36.8)
High income 4132 (35.1) 9098 (38.6) 9974 (42.4) 6028 (50.5)
Child's sex, male 70795 5672 (48.1) 11535 (48.9) 11912 (50.7) 6003 (50.3) <0.001
Maternal education level 64352
Primary 2806 (25.6) 4681 (21.8) 4077 (19.2) 1682 (15.8) <0.001
Secondary 5077 (46.4) 9841 (45.8) 9286 (43.7) 4186 (39.3)
Terciary 3055 (27.9) 6987 (32.5) 7889 (37.1) 4785 (44.9)
Ever breastfed 67150 8411 (76.3) 17494 (78.7) 18075 (80.7) 9516 (82.8) <0.001
Siblings, yes 64992 8781 (80.9) 17904 (82.8) 18300 (84.8) 9384 (85.8) <0.001
Pets at home 66132 4419 (39.3) 8106 (36.5) 7630 (34.9) 3610 (33.2) <0.001
Paracetamol use for fever 68480 7562 (66.6) 15054 (66.2) 14634 (64.3) 7214 (62.2) <0.001
Data are n (%). P value derived from chi2 test.
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Table 3. Associations* (odds ratio and 95% CI) between Healthy Lifestyle Index and symptoms of asthma, rhino-conjunctivitis,
and eczema at 6–7 years of age, ISAAC Phase Three.
Healthy Lifestyle Index points
N 0-1 2 3 4-5 p trend Per 1-point increase
Current wheeze
Unadjusted 69987 1 0.95 (0.89, 1.02) 0.79 (0.73, 0.85) 0.67 (0.62, 0.73) <0.001 0.88 (0.86, 0.90)
Adjusted1 69987 1 0.95 (0.88, 1.02) 0.78 (0.73, 0.84) 0.67 (0.61, 0.73) <0.001 0.88 (0.86, 0.90)
Adjusted2 61122 1 0.93 (0.86, 1.00) 0.76 (0.70, 0.82) 0.63 (0.58, 0.70) <0.001 0.86 (0.84, 0.89)
Adjusted3 61122 1 0.93 (0.87, 1.01) 0.77 (0.71, 0.83) 0.66 (0.60, 0.72) <0.001 0.87 (0.85, 0.89)
Asthma ever
Unadjusted 69369 1 0.92 (0.85, 0.99) 0.83 (0.77, 0.90) 0.73 (0.67, 0.80) <0.001 0.91 (0.89, 0.93)
Adjusted1 69369 1 0.91 (0.84, 0.98) 0.82 (0.76, 0.89) 0.72 (0.66, 0.79) <0.001 0.91 (0.88, 0.93)
Adjusted2 55494 1 0.88 (0.81, 0.96) 0.77 (0.70, 0.84) 0.64 (0.58, 0.71) <0.001 0.88 (0.85, 0.90)
Adjusted4 55494 1 0.89 (0.81, 0.97) 0.79 (0.72, 0.86) 0.67 (0.60, 0.74) <0.001 0.89 (0.86, 0.92)
Current symptoms of
rhinoconjunctivitis
Unadjusted 59091 1 0.98 (0.91, 1.07) 0.91 (0.84, 0.99) 0.86 (0.79, 0.95) <0.001 0.96 (0.93, 0.98)
Adjusted1 59091 1 0.98 (0.91, 1.06) 0.91 (0.84, 0.98) 0.86 (0.78, 0.94) <0.001 0.95 (0.93, 0.98)
Adjusted2 53366 1 0.98 (0.90, 1.07) 0.90 (0.83, 0.98) 0.84 (0.76, 0.92) <0.001 0.95 (0.92, 0.97)
Adjusted5 53366 1 0.99 (0.91, 1.07) 0.92 (0.84, 1.00) 0.86 (0.78, 0.95) 0.001 0.96 (0.93, 0.98)
Hay fever ever
Unadjusted 66830 1 1.03 (0.95, 1.11) 1.00 (0.92, 1.08) 0.96 (0.87, 1.05) 0.189 0.98 (0.96, 1.01)
Adjusted1 66830 1 1.02 (0.95, 1.11) 0.99 (0.91, 1.07) 0.95 (0.87, 1.04) 0.140 0.98 (0.96, 1.01)
Adjusted2 53747 1 1.03 (0.95, 1.13) 0.99 (0.90, 1.08) 0.93 (0.83, 1.03) 0.060 0.97 (0.95, 1.00)
Adjusted6 53747 1 1.03 (0.94, 1.13) 0.99 (0.90, 1.08) 0.92 (0.83, 1.02) 0.049 0.97 (0.94, 1.00)
Current symptoms of
eczema
Unadjusted 66147 1 0.91 (0.84, 0.99) 0.89 (0.82, 0.96) 0.86 (0.78, 0.94) 0.002 0.96 (0.93, 0.99)
Adjusted1 66147 1 0.91 (0.84, 0.99) 0.89 (0.82, 0.97) 0.86 (0.78, 0.95) 0.003 0.96 (0.94, 0.99)
Adjusted2 52689 1 0.90 (0.82, 0.99) 0.87 (0.79, 0.96) 0.86 (0.77, 0.96) 0.005 0.96 (0.93, 0.99)
Adjusted6 52689 1 0.89 (0.81, 0.98) 0.86 (0.78, 0.95) 0.84 (0.75, 0.94) 0.002 0.96 (0.93, 0.99)
Eczema ever
Unadjusted 66507 1 1.01 (0.95, 1.08) 0.99 (0.93, 1.06) 1.10 (1.02, 1.18) 0.039 1.03 (1.01, 1.05)
Adjusted1 66507 1 1.01 (0.95, 1.08) 0.99 (0.93, 1.06) 1.10 (1.02, 1.18) 0.041 1.03 (1.01, 1.05)
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Adjusted2 58164 1 1.02 (0.95, 1.09) 1.02 (0.96, 1.10) 1.15 (1.07, 1.25) <0.001 1.04 (1.02, 1.07)
Adjusted7 58164 1 0.98 (0.92, 1.05) 0.97 (0.90, 1.04) 1.05 (0.97, 1.13) 0.346 1.01 (0.99, 1.04)
*Mixed-effects logistic regression including a random intercept for centre.
1Adjusted for child’s sex, gross national income per capita (GNI) and region of the world.
2Children with complete covariate data, adjusted for child’s sex, GNI and region of the world
3Multivariate analysis (children with complete covariate data), adjusted for child’s sex, gross national income, region of the world, breastfeeding, pets at home, and
paracetamol use for fever in the first year.
4Multivariate analysis (children with complete covariate data), adjusted for child’s sex, GNI, region of the world, maternal education, siblings, pets at home, and
paracetamol use for fever in the first year.
5Multivariable analysis (children with complete covariate data), adjusted for child’s sex, GNI, region of the world, pets at home, and paracetamol use for fever in the first
year.
6Multivariable analysis (children with complete covariate data), adjusted for child’s sex, GNI, region of the world, maternal education, breastfeeding, siblings, and
paracetamol use for fever in the first year.
7Multivariable analysis (children with complete covariate data), adjusted for child’s sex, GNI, region of the world, maternal education, breastfeeding, and paracetamol
use for fever in the first year.
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Table 4. Population attributable risk fractions* for 4 or 5 Healthy Lifestyle Index factors, ISAAC
Phase Three.
Current
wheeze
Asthma
ever
Current symptoms of
rhinoconjunctivitis
Current symptoms
of eczema
All regions 20.2 (12.8 to 27.6) 16.4 (10.2 to 22.6) 6.0 (-2.8 to 14.8) 4.8 (0.2 to 9.3)
Region of the world
Western Europe 25.5 (18.5 to 32.6) 16.4 (7.4 to 25.3) 10.8 (2.3 to 19.3) 3.1 (-2.6 to 8.9)
Northern and Eastern Europe 10.5 (-7.5 to 28.6) 26.3 (6.8 to 45.7) -20.2 (-33.5 to -6.9) -7.0 (-20.1 to 6.1)
Eastern Mediterranean 8.3 (-25.9 to 42.6) 2.7 (-29.5 to 34.9) -7.8 (-49.8 to 34.2) -0.9 (-54.9 to 53.1)
Latin American 25.8 (4.0 to 47.5) 17.6 (0.3 to 35.0) 17.7 (-1.1 to 36.5) 11.8 (-0.2 to 23.8)
Asia-Pacific 16.6 (-1.1 to 34.4) 19.8 (-8.9 to 48.5) 11.6 (-2.7 to 25.9) 15.5 (-4.5 to 35.4)
Oceania 6.58 (-0.08 to 13.2) 10.2 (4.8 to 15.6) -15.9 (-53.6 to 21.8) 2.8 (-4.5 to 10.1)
*Data represents the proportion (95% confidence intervals) of the cases attributable to not being in the lowest risk exposure
group (i.e. 4 or 5 healthy lifestyle factors). Negative values indicate no benefit from HLI.
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Figure legends
Figure 1. Associations* (odds ratio and 95% CI) between 1-point increase in Healthy
Lifestyle Index (HLI) during childhood and current wheeze1 (A), current symptoms of
rhino-conjunctivitis2 (B), and current symptoms of eczema3 (C), ISAAC Phase Three.
*Centre-specific odds ratios and 95% confidence intervals from meta-analysis using random effects.
For each centre, the mean HLI score is stated in brackets.
1Models adjusted for child’s sex, breastfeeding and pets at home. Punta Arenas and Caracas centers not
included because of incomplete data.
2Models adjusted for child’s sex and pets at home. Poznan, Ciudad Victoria and Caracas centers not included
because of incomplete data.
3Models adjusted for child’s sex, maternal education level, breastfeeding and siblings. Punta Arenas, Caracas,
Fukuoka, Singapore, and Al-Khod centers not included because of incomplete data.
Figure 2. Associations* (odds ratio and 95% CI) between 1-point increase in Healthy
Lifestyle Index (HLI) during childhood and asthma ever1 (A), hay fever ever2 (B), and ever
eczema3 (C) in children aged 6-7 years, the ISAAC Phase Three.
*Centre-specific odds ratios and 95% confidence intervals from meta-analysis using random effects.
For each centre, the mean HLI score is stated in brackets.
1Models adjusted for child’s sex, maternal education level, siblings and pets at home. Singapore, Al-Khod
and Caracas centers not included because of incomplete data.
2Models adjusted for child’s sex, maternal education level, breastfeeding and siblings. Punta Arenas, Caracas,
Singapore and Al-Khod centers not included because of incomplete data.
3Models adjusted for child’s sex, maternal education level and breastfeeding. Punta Arenas, Caracas,
Fukuoka and Al-Khod centers not included because of incomplete data.
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